The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지

Therapeutic Potential of Atopy-camp: A pilot study

  • Lee, Nam-Ryul (Department of Oriental Pediatrics of Oriental Medicine College, Daejeon University) ;
  • Kim, Hyung-Geug (Liver and Immunology Research Center of Oriental Medicine College, Daejeon University) ;
  • Seo, Kyoung-Suk (Student Counseling Center, Daejeon Oriental Hospital, Daejeon University) ;
  • Son, Chang-Gue (Liver and Immunology Research Center of Oriental Medicine College, Daejeon University)
  • Received : 2010.10.22
  • Accepted : 2010.11.08
  • Published : 2010.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: This study investigated the therapeutic possibility of natural therapy in atopy-camp for children with atopic dermatitis. Methods: 30 children (19 boys and 11 girls, median age 11.5 years, ranging from 9 to 15) participated in natural environment-based activities in a camp-village located in Geumsan-gun for five days. Assessment of symptom change was conducted by self-reporting numeric scale (NRS) for pruritus and sleeping difficulty, investigator global assessment (IGA), eczema area and severity index (EASI score), serum histamine and IgE concentration before and after the camp period. Statistical significance was analyzed by paired t-test. Results: NRS for pruritus ($4.7{\pm}2.0$ into $4.3{\pm}2.1$), sleeping difficulty ($3.1{\pm}2.1$ into $2.9{\pm}2.0$), and serum histamine concentration ($4.27{\pm}7.39$ mol / L into $3.21{\pm}6.08$ mol / L) showed positive changes but didn't reach statistical significance (p > 0.05). IGA ($3.8{\pm}0.9$ into $4.13{\pm}1.0$), while EASI score ($10.8{\pm}9.7$ into $9.1{\pm}9.2$) and IgE ($408{\pm}320$ IU / mL into $385{\pm}3.8$ IU / mL) were significantly improved (p < 0.01). Conclusions: In spite of the limitation of the clinical trial protocol, this study may provide the possibility of natural environment-based therapy for children with atopic dermatitis.

Keywords

References

  1. Torres-Borrego J, Molina-Terán AB, Montes- Mendoza C. Prevalence and associated factors of allergic rhinitis and atopic dermatitis in children. Allergol Immunopathol. 2008;36(2):90-100. https://doi.org/10.1157/13120394
  2. De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA. Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol. 2009;129(1):14-30. https://doi.org/10.1038/jid.2008.259
  3. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351(9111):1225-32. https://doi.org/10.1016/S0140-6736(97)07302-9
  4. Bae JM, Shin KS. Estimating the prevalence of atopic dermatitis in school students of Jejudo, Korea. J Prev Med Public Health. 2009;42(3):171-6. https://doi.org/10.3961/jpmph.2009.42.3.171
  5. Hong SJ, Ahn KM, Lee SY, Kim KE. The prevalences of asthma and allergic diseases in Korean Children. Pediatr Allergy Respir Dis. 2008 18:15-25.
  6. Simpson EL. Atopic dermatitis: a review of topical treatment options. Curr Med Res Opin. 2010;26(3):633-40. https://doi.org/10.1185/03007990903512156
  7. Forte WC, Sumita JM, Rodrigues AG, Liuson D, Tanaka E. Rebound phenomenon to systemic corticosteroid in atopic dermatitis. Allergol Immunopathol (Madr). 2005;33(6):307-11. https://doi.org/10.1016/S0301-0546(05)73248-1
  8. Beattie PE, Finlan LE, Kernohan NM, Thomson G, Hupp TR, Ibbotson SH. The effect of ultraviolet (UV) A1, UVB and solar-simulated radiation on p53 activation and p21. Br. J Dermatol. 2005 152(5):1001-8. https://doi.org/10.1111/j.1365-2133.2005.06557.x
  9. Zhang W, Leonard T, Bath-Hextall F, Chambers CA, Lee C, Humphreys R, et al. Chinese herbal medicine for atopic eczema. Cochrane Database Syst Rev (2). 2005 CD002291.
  10. Hon KL, Leung TF, Ng PC, Lam MC, Kam WY, Wong KY, et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br. J Dermatol. 2007;157(2):357-63. https://doi.org/10.1111/j.1365-2133.2007.07941.x
  11. Available from URL: http://blog.daum.net/maerye/8540563
  12. Available from URL: http://biz.heraldm.com/common/Detail.jsp?newsMLId=20101008000730
  13. Veraldi S, Menter A, Innocenti M. Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, doubleblind, controlled trial. J Eur Acad Dermatol Venereol. 2008;22(3):290-6. https://doi.org/10.1111/j.1468-3083.2007.02404.x
  14. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001;10(1):11-8. https://doi.org/10.1034/j.1600-0625.2001.100102.x
  15. Lee HY, Lee JR, Roh JY. Epidemiological Features of Preschool Childhood Atopic Dermatitis in Incheon. Korean J. Dermatol. 2009;47(2):164-71.
  16. Kim EH, Jang YH, Lee ES. Epidemiological Features of Childhood Atopic Dermatitis in Suwon. Korean J. Dermatol. 2010;48(6):482-93.
  17. Kim GE, Jung SK, Jung HJ, Jang HJ. Effects of Arctium lappa Linne on the DNFB-induced allergic dermatitis. J Orient. Int. Med. 2010;31(2):201-11.
  18. Ko HY, Kim DH. Study on Combination of External Gosamgamibang and Internal Chenggihaedok-san for the Treatment of Atopic Dermatitis. Korean J Orient. Physiology & Pathology. 2009;23(6):1282-91.
  19. Biro T, Ko MC, Bromm B, Wei ET, Bigliardi P, Siebenhaar F, et al. How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp Dermatol. 2005;14:225-40.
  20. Mayser P, Kupfer J, Nemetz D, Schäfer U, Nilles M, Hort W, et al. Treatment of head and neck dermatitis with ciclopirox olamine cream--results of a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2006;19(3):153-8. https://doi.org/10.1159/000092596
  21. Paller AS, Lebwohl M, Fleischer AB Jr, Antaya R, Langley RG, Kirsner RS, et al. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol. 2005;52(5):810-22. https://doi.org/10.1016/j.jaad.2004.12.038
  22. Ahmed I, Nasreen S. Frequency of raised serum IgE level in childhood atopic dermatitis. J Pak Med Assoc. 2007;57(9):431-4.
  23. Metwally SS, Mosaad YM, Abdel-Samee ER, El-Gayyar MA, Abdel-Aziz AM, El-Chennawi FA. IL-13 gene expression in patients with atopic dermatitis: relation to IgE level and to disease severity. Egypt J Immunol. 2004;11(2):171-7.
  24. Simpson AB, Yousef E, Hossain J. Evaluation of the relationship between IgE level and skin superinfection in children with atopic dermatitis. Allergy Asthma Proc. 2010;31(3):232-7. https://doi.org/10.2500/aap.2010.31.3335
  25. Lee S, Noh GW, Lee KY. Clinical application of histamine prick test for food challenge in atopic dermatitis. J Korean Med Sci. 2001;16(3):276-82. https://doi.org/10.3346/jkms.2001.16.3.276
  26. Arndt J, Smith N, Tausk F. Stress and atopic dermatitis. Curr Allergy Asthma Rep. 2008;8(4):312. https://doi.org/10.1007/s11882-008-0050-6
  27. Weber MB, Fontes Neto Pde T, Prati C, Soirefman M, Mazzotti NG, Barzenski B, et al. Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. J Eur Acad Dermatol Venereol. 2008;22(8):992-7. https://doi.org/10.1111/j.1468-3083.2008.02697.x